Oragenics Extends Collaboration To Develop Vaccines Against Future Variants of Coronaviruses
UF startup and UF Innovate | Sid Martin Biotech graduate Oragenics, Inc. announced it has extended a licensing and collaboration agreement with the National Research Council of Canada (NRC) that enables Oragenics to pursue an intranasal vaccine designed to protect against future variants of coronaviruses.
Resilience To Get $164M for Site Expansion
Resilience, a manufacturing and technology company that recently acquired Ology Bioservices, will receive $164M to update and expand a site in Ontario.